Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat

Neurotoxicology and Teratology

Volumn 34, Issue 1, 2012, Pages 206-213

  Thompson, V B ^a,b   Koprich, J B ^c   Chen, E Y ^c   Kordower, J H ^c   Terpstra, B T ^a,b   Lipton, J W ^b,c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hippocampus; Locus coeruleus; Norepinephrine; Prefrontal cortex

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; NISOXETINE; NORADRENALIN TRANSPORTER;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN STEM RESPONSE; CONTROLLED STUDY; DENTATE GYRUS; EXPERIMENTAL RAT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; LIMBIC CORTEX; LOCUS CERULEUS; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PREFRONTAL CORTEX; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ADRENERGIC NEURONS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANIMALS, NEWBORN; CELL COUNT; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICROSCOPY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE FIBERS, MYELINATED; NEUROGENESIS; NEUROTOXICITY SYNDROMES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84856231953     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2011.09.005     Document Type: Article

References (62)

1. Angel I., Schoemaker H., Arbilla S., Galzin A.M., Berry C., Niddam R., et al. Sl-84.0418 - a novel, potent and selective alpha-2 adrenoceptor antagonist - invitro pharmacological profile. J Pharmacol Exp Ther 1992, 263:1327-1333.
2. Antonopoulos J., Latsari M., Dori I., Chiotelli M., Parnavelas J.G., Dinopoulos A. Noradrenergic innervation of the developing and mature septal area of the rat. J Comp Neurol 2004, 476:80-90.
3. Battaglia G., Brooks B.P., Kulsakdinun C., De Souza E.B. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. Eur J Pharmacol 1988, 149:159-163.
4. Bayer S.A., Altman J. Hippocampal development in the rat: cytogenesis and morphogenesis examined with autoradiography and low-level X-irradiation. J Comp Neurol 1974, 158:55-79.
5. Brandt I. Brain growth, fetal malnutrition, and clinical consequences. J Perinat Med 1981, 9:3-26.
6. Broening H.W., Morford L.L., Inman-Wood S.L., Fukumura M., Vorhees C.V. 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci 2001, 21:3228-3235.
7. Cabrera T.M., Levy A.D., Li Q., van de Kar L.D., Battaglia G. Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: evidence for selective long-term dysfunction of serotonin pathways in brain. Synapse 1993, 15:198-208.
8. Chen J.C., Turiak G., Galler J., Volicer L. Postnatal changes of brain monoamine levels in prenatally malnourished and control rats. Int J Dev Neurosci 1997, 15:257-263.
9. Church M.W., Rauch H.C. Prenatal cocaine exposure in the laboratory mouse: effects on maternal water consumption and offspring outcome. Neurotoxicol Teratol 1992, 14:313-319.
10. Dellu F., Piazza P.V., Mayo W., Le Moal M., Simon H. Novelty-seeking in rats-biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology 1996, 34:136-145.
11. Devoto P., Flore G., Pani L., Gessa G.L. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 2001, 6:657-664.
12. Dias R., Honey R.C. Involvement of the rat medial prefrontal cortex in novelty detection. Behav Neurosci 2002, 116:498-503.
13. Dobbing J. Vulnerable periods of brain development. Lipids, malnutrition & the developing brain, Ciba Found Symp 1971, 9-29.
14. Guiard B.P., El Mansari M., Blier P. Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus. Mol Pharmacol 2008, 74:1463-1475.
15. Heyser C.J., Molina V.A., Spear L.P. A fostering study of the effects of prenatal cocaine exposure: I. Maternal behaviors. Neurotoxicol Teratol 1992, 14:415-421.
16. Holson R.R., Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol 1992, 14:221-228.
17. Holton K.L., Loder M.K., Melikian H.E. Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat Neurosci 2005, 8:881-888.
18. Jenkins T.A., Amin E., Pearce J.M., Brown M.W., Aggleton J.P. Novel spatial arrangements of familiar visual stimuli promote activity in the rat hippocampal formation but not the parahippocampal cortices: a c-fos expression study. Neuroscience 2004, 124:43-52.
19. Johns J.M., McMurray M.S., Hofler V.E., Jarrett T.M., Middleton C.L., Elliott D.L., et al. Cocaine disrupts pup-induced maternal behavior in juvenile and adult rats. Neurotoxicol Teratol 2007, 29:634-641.
20. Johnston L., O'Malley P., Bachman J., Shulenberg J. Monitoring the Future: National Results on Adolescent Drug Abuse, Overview of Key Findings, NIH Publication No 08-6418 2008.
21. Kelly P.A., Ritchie I.M., Quate L., McBean D.E., Olverman H.J. Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain. Br J Pharmacol 2002, 137:963-970.
22. Kilbourn M.R., Sherman P., Abbott L.C. Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering. Synapse 1998, 30:205-210.
23. Kitchigina V., Vankov A., Harley C., Sara S.J. Novelty-elicited, noradrenaline-dependent enhancement of excitability in the dentate gyrus. Eur J Neurosci 1997, 9:41-47.
24. Koprich J.B., Chen E.Y., Kanaan N.M., Campbell N.G., Kordower J.H., Lipton J.W. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats. Neurotoxicol Teratol 2003, 25:509-517.
25. Lee I., Kesner R.P. Time-dependent relationship between the dorsal hippocampus and the prefrontal cortex in spatial memory. J Neurosci 2003, 23:1517-1523.
26. Levitt P., Moore R.Y. Development of the noradrenergic innervation of neocortex. Brain Res 1979, 162:243-259.
27. Lipton J.W., Tolod E.G., Thompson V.B., Pei L., Paumier K.L., Terpstra B.T., et al. 3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture. Neuropharmacology 2008, 55:851-859.
28. Loy R., Moore R.Y. Ontogeny of the noradrenergic innervation of the rat hippocampal formation. Anat Embryol (Berl) 1979, 157:243-253.
29. Marichich E.S., Molina V.A., Orsingher O.A. Persistent changes in central catecholaminergic system after recovery of perinatally undernourished rats. J Nutr 1979, 109:1045-1050.
30. Mavridis M., Degryse A.D., Lategan A.J., Marien M.R., Colpaert F.C. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience 1991, 41:507-523.
31. Mordenti J., Chappell W. The use of interspecies scaling in toxicokinetics. Toxicokinetics and New Drug Development 1989, 42-96. Pergamon Press, New York. A. Yacobi, J.P. Skelly, V.K. Batra (Eds.).
32. Moron J.A., Brockington A., Wise R.A., Rocha B.A., Hope B.T. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 2002, 22:389-395.
33. Noguchi T., Yoshida Y., Chiba S. Effects of psychological stress on monoamine systems in subregions of the frontal cortex and nucleus accumbens of the rat. Brain Res 2001, 916:91-100.
34. Otmakhova N.A., Lewey J., Asrican B., Lisman J.E. Inhibition of perforant path input to the CA1 region by serotonin and noradrenaline. J Neurophysiol 2005, 94:1413-1422.
35. Palacios J.M., Hoyer D., Cortes R. Alpha-1-adrenoceptors in the mammalian brain - similar pharmacology but different distribution in rodents and primates. Brain Res 1987, 419:65-75.
36. Palacios J.M., Kuhar M.J. Beta-adrenergic-receptor localization in rat-brain by light microscopic autoradiography. Neurochem Int 1982, 4:473-490.
37. Paxinos G., Watson C., Pennisi M., Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods 1985, 13:139-143.
38. Rainbow T.C., Parsons B., Wolfe B.B. Quantitative autoradiography of beta-1-adrenergic and beta-2-adrenergic receptors in rat-brain. Proc Natl Acad Sci U S A Am Biol Sci 1984, 81:1585-1589.
39. Rebec G., Grabner C., Johnson M., Pierce R., Bardo M. Transient increase in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience 1996, 76:707-714.
40. Rosario L.A., Abercrombie E.D. Individual differences in behavioral reactivity: correlation with stress-induced norepinephrine efflux in the hippocampus of Sprague-Dawley rats. Brain Res Bull 1999, 48:595-602.
41. SAMHSA National Survey on Drug Use and Health 2009, D.o.H.a.H. Services (Ed.).
42. Saunders C., Ferrer J.V., Shi L., Chen J., Merrill G., Lamb M.E., et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci U S A 2000, 97:6850-6855.
43. Seidler F.J., Bell J.M., Slotkin T.A. Undernutrition and overnutrition in the neonatal rat: long-term effects on noradrenergic pathways in brain regions. Pediatr Res 1990, 27:191-197.
44. Shiraishi H., Suzuki A., Fukasawa T., Aoshima T., Ujiie Y., Ishii G., et al. Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participants. Psychiatr Genet 2006, 16:55-58.
45. Siuta M.A., Robertson S.D., Kocalis H., Saunders C., Gresch P.J., Khatri V., et al. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol 2010, 8:e1000393.
46. Smith R.J., Aston-Jones G. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 2008, 213:43-61.
47. Sorkina T., Hoover B.R., Zahniser N.R., Sorkin A. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 2005, 6:157-170.
48. Spear L.P., Kirstein C.L., Bell J., Yoottanasumpun V., Greenbaum R., O'Shea J., et al. Effects of prenatal cocaine exposure on behavior during the early postnatal period. Neurotoxicol Teratol 1989, 11:57-63.
49. Spear L.P., Kirstein C.L., Frambes N.A. Cocaine effects on the developing central nervous system: behavioral, psychopharmacological, and neurochemical studies. Ann N Y Acad Sci 1989, 562:290-307.
50. Strange B.A., Fletcher P.C., Henson R.N., Friston K.J., Dolan R.J. Segregating the functions of human hippocampus. Proc Natl Acad Sci U S A 1999, 96:4034-4039.
51. Thompson V.B., Heiman J., Chambers J.B., Benoit S.C., Buesing W.R., Norman M.K., et al. Long-term behavioral consequences of prenatal MDMA exposure. Physiol Behav 2009, 96:593-601.
52. Uprichard D.C., Bechtel W.D., Rouot B.M., Snyder S.H. Multiple apparent alpha-noradrenergic receptor-binding sites in rat-brain - effect of 6-hydroxydopamine. Mol Pharmacol 1979, 16:47-60.
53. Ventura R., Latagliata E.C., Morrone C., La Mela I., Puglisi-Allegra S. Prefrontal norepinephrine determines attribution of "high" motivational salience. PLoS One 2008, 3:e3044.
54. Ventura R., Morrone C., Puglisi-Allegra S. Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc Natl Acad Sci U S A 2007, 104:5181-5186.
55. West M.J., Gundersen H.J. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 1990, 296:1-22.
56. Wiggins R.C., Fuller G.N., Seifert W.E., Butler I.J., Gottesfeld Z. Catecholamines in rat brain following postnatal undernutrition and nutritional rehabilitation. J Neurosci Res 1982, 8:651-656.
57. Williams M., Morford L., Wood S., Rock S., AE M., Fukumura M., et al. Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res 2003, 968:89-101.
58. Williams M.T., Morford L.L., Wood S.L., Rock S.L., McCrea A.E., Fukumura M., et al. Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res 2003, 968:89-101.
59. Wills T.A., Vaccaro D., McNamara G. Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: an application of Cloninger's theory. J Subst Abuse 1994, 6:1-20.
60. Winslow J.T., Insel T.R. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 1990, 254:212-220.
61. Winstock A., Griffiths P., Stewart D. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 2001, 64:9-17.
62. Yamamoto B.K., Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 1998, 71:274-280.